"In 435s cells, treatment with the c-Abl and Arg inhibitors, imatinib or nilotinib, decreased cathepsin L, B activation, as the lysosomal double chain forms were reduced whereas proforms (golgi and early endosome) and intermediate forms (late endosome) accumulated (XREF_FIG -left and XREF_SUPPLEMENTARY)."